Singapore markets closed

ARS Pharmaceuticals, Inc. (SPRY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.35+0.26 (+3.21%)
At close: 04:00PM EDT
8.27 -0.08 (-0.96%)
After hours: 06:36PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
30
30
1,316
5,506
17,835
Operating expenses
Research development
20,266
20,266
18,376
20,273
14,070
Selling general and administrative
47,284
47,284
18,456
4,687
4,234
Total operating expenses
67,550
67,550
36,832
24,960
18,304
Operating income or loss
-67,520
-67,520
-35,516
-19,454
-469
Total other income/expenses net
13,155
13,155
834
-789
-596
Income before tax
-54,365
-54,365
-34,682
-20,243
-1,065
Income from continuing operations
-54,365
-54,365
-34,682
-20,243
-1,065
Net income
-54,365
-54,365
-34,682
-20,243
-1,065
Net income available to common shareholders
-54,365
-54,365
-34,682
-20,243
-1,065
Basic EPS
-0.64
-
-0.87
-0.22
-0.01
Diluted EPS
-0.64
-
-0.87
-0.22
-0.01
Basic average shares
95,796
-
39,956
93,770
93,770
Diluted average shares
95,796
-
39,956
93,770
93,770